Cardinal Health, Inc. reports results for the quarter ended September 30 - Earnings Summary
Cardinal Health, Inc. CAH.N reported quarterly adjusted earnings of $3.26 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $2.55. The mean expectation of sixteen analysts for the quarter was for earnings of $2.94 per share. Wall Street expected results to range from $2.88 to $3.06 per share.
Revenue rose 5.5% to $67.51 billion from a year ago; analysts expected $66.59 billion.
Cardinal Health, Inc.'s reported EPS for the quarter was $2.38.
The company reported quarterly net income of $554 million.
Cardinal Health, Inc. shares had risen by 17.7% this quarter and gained 27.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 2.2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Cardinal Health, Inc. is $280.00, about 6.5% above its last closing price of $261.93
This summary was machine generated from LSEG data November 5 at 02:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 2.94 | 3.26 | Beat |
Jun. 30 2026 | 2.42 | 2.60 | Beat |
Mar. 31 2026 | 2.79 | 3.17 | Beat |
Dec. 31 2025 | 2.38 | 2.63 | Beat |